Actelion Ltd.
is a leading
biopharmaceutical
company focused
on the discovery,
development
and commercialization
of innovative drugs
for diseases
with significant
unmet medical needs.

Annual General Meeting 2017

Actelion issues invitation to the upcoming
2017 Annual General Meeting of Shareholders.

Actelion issues invitation to the upcoming
2017 Annual General Meeting of Shareholders.

Global Actelion

Hotspot of possibilities

Actelion has subsidiaries in over 30 countries, covering all major pharmaceutical markets worldwide

Hotspot of possibilities

Actelion has subsidiaries in over 30 countries, covering all major pharmaceutical markets worldwide

Shareprice

ATLN SIX Swiss Exchange

Shareprice
At 17:30:51 CET 27/03/2017
CHF 273,00Up Down image
-1,30 (-0,47%)